← Product Code [DID](/submissions/TX/subpart-d%E2%80%94clinical-toxicology-test-systems/DID) · K780048

# AMINOGLYCOSIDE TEST SYSTEM (K780048)

_Nichols Institute Diagnostics · DID · Jan 20, 1978 · Clinical Toxicology · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/IM/subpart-d%E2%80%94clinical-toxicology-test-systems/DID/K780048

## Device Facts

- **Applicant:** Nichols Institute Diagnostics
- **Product Code:** [DID](/submissions/TX/subpart-d%E2%80%94clinical-toxicology-test-systems/DID.md)
- **Decision Date:** Jan 20, 1978
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 862.3900
- **Device Class:** Class 2
- **Review Panel:** Clinical Toxicology

## Regulatory Identification

A tobramycin test system is a device intended to measure tobramycin, an aminoglycoside antibiotic drug, in plasma and serum. Measurements obtained by this device are used in the diagnosis and treatment of tobramycin overdose and in monitoring levels of tobramycin to ensure appropriate therapy.

---

**Source:** [https://fda.innolitics.com/submissions/IM/subpart-d%E2%80%94clinical-toxicology-test-systems/DID/K780048](https://fda.innolitics.com/submissions/IM/subpart-d%E2%80%94clinical-toxicology-test-systems/DID/K780048)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com